HomeAQST • NASDAQ
add
Aquestive Therapeutics Inc
Previous close
$4.81
Day range
$4.75 - $5.06
Year range
$1.84 - $6.23
Market cap
421.82M USD
Avg Volume
1.57M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 13.54M | 4.15% |
Operating expense | 17.40M | 64.40% |
Net income | -11.51M | -465.55% |
Net profit margin | -84.99 | -443.07% |
Earnings per share | -0.13 | -333.33% |
EBITDA | -8.13M | -284.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 77.89M | 212.61% |
Total assets | 109.96M | 84.97% |
Total liabilities | 155.38M | -4.31% |
Total equity | -45.42M | — |
Shares outstanding | 91.18M | — |
Price to book | -9.62 | — |
Return on assets | -18.21% | — |
Return on capital | 498.98% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -11.51M | -465.55% |
Cash from operations | -11.88M | -406.18% |
Cash from investing | -80.00K | 47.02% |
Cash from financing | -17.00K | -100.34% |
Net change in cash | -11.98M | -582.75% |
Free cash flow | -6.78M | -181.73% |
About
Founded
2004
Headquarters
Website
Employees
135